Bioregenx (BRGX) Inventory (2023 - 2026)

Bioregenx's Inventory history runs 4 years deep, the most recent figure standing at $92806.0 for Q1 2026.

• On a quarterly basis, Inventory fell 33.92% year-over-year to $92806.0 in Q1 2026; TTM through Mar 2026 was $92806.0, a 33.92% decrease from a year earlier, with the FY2025 full-year figure at $106931.0, down 3.75% from the prior year.
• Inventory eased to $92806.0 in Q1 2026 per BRGX's latest filing, from $106931.0 in the prior quarter.
• Across five years, Inventory topped out at $217529.0 in Q4 2023 and bottomed at $92806.0 in Q1 2026.
• The 4-year median for Inventory is $137333.0 (2025), against an average of $142839.7.
• Across the five-year window, Inventory slumped 48.93% in 2024 and dropped 3.75% in 2025, its largest moves.
• Year by year, Inventory stood at $217529.0 in 2023, then slumped by 48.93% to $111094.0 in 2024, then retreated by 3.75% to $106931.0 in 2025, then fell by 13.21% to $92806.0 in 2026.
• Per Business Quant, the three latest BRGX Inventory figures stand at $92806.0 (Q1 2026), $106931.0 (Q4 2025), and $109378.0 (Q3 2025).